Differential Expression of BCL-2 Family Proteins in ALK-Positive and ALK-Negative Anaplastic Large Cell Lymphoma of T/Null-Cell Lineage
- 1 August 2001
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 159 (2), 527-535
- https://doi.org/10.1016/s0002-9440(10)61724-5
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Aberrant ALK Tyrosine Kinase SignalingThe American Journal of Pathology, 2000
- The impact of bcl-2 expression and bax deficiency on prostate homeostasis in vivoOncogene, 2000
- Apoptosis induced by the myelodysplastic syndrome-associated NPM-MLF1 chimeric proteinOncogene, 1999
- Expression and function of CD95 (FAS/APO‐1) in leukaemia‐lymphoma tumour linesBritish Journal of Haematology, 1997
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on 18Cell, 1985
- Cloning of the Chromosome Breakpoint of Neoplastic B Cells with the t(14;18) Chromosome TranslocationScience, 1984